GM Confirms 8.3L Duramax for 2027 HD Trucks; Stock Rises 2.1%
Markets Daniel Marsh

GM Confirms 8.3L Duramax for 2027 HD Trucks; Stock Rises 2.1%

General Motors confirmed an 8.3-liter Duramax diesel for its 2027 heavy-duty pickups, sending shares up 2.1% to $83.95. Key specs and pricing remain undisclosed.

GM F STLA
Gravity Token Holds 68% Weekly Surge Despite 39% Weekend Pullback
Crypto Sarah Chen

Gravity Token Holds 68% Weekly Surge Despite 39% Weekend Pullback

Gravity's G token rose 67.8% in a week but fell 39% from Sunday's high. Fast Withdraw cuts bridge time to 10 minutes, yet supply and deadline risks remain.

IBIT
Nasdaq Hits Record as Tech Soars, Oil Retreats
Markets Daniel Marsh

Nasdaq Hits Record as Tech Soars, Oil Retreats

The Nasdaq Composite surged to a record close, up 2.3%, while the S&P 500 finished just shy of its peak. Oil prices fell sharply, easing inflation worries.

META INTC AMD QCOM
AMD Rally on Unverified Price Hike Speculation
Analysis Daniel Marsh

AMD Rally on Unverified Price Hike Speculation

AMD closed at $615.52, up 9.95%, but no confirmation of a reported 10% Q4 price hike. Analysts' average target implies 4.7% upside, with data center growth driving sentiment.

AMD TSM
Fifth Third to Rebrand Detroit Ballpark as Fifth Third Park
Analysis Daniel Marsh

Fifth Third to Rebrand Detroit Ballpark as Fifth Third Park

Fifth Third Bancorp will rename Detroit's Comerica Park to Fifth Third Park for the 2027 season. Terms undisclosed; FITB shares rose 0.8%.

FITB
Bungie Revives Destiny 2 Vaulted Content; Sony's Investment Strategy in Focus
Analysis Daniel Marsh

Bungie Revives Destiny 2 Vaulted Content; Sony's Investment Strategy in Focus

Bungie has started rebuilding vaulted Destiny 2 content, reversing an earlier sunsetting decision. Sony's $3.6B acquisition faces renewed scrutiny as investors await monetization details.

SONY
Moderna Surges 13% as Key Melanoma Data Looms
Analysis Daniel Marsh

Moderna Surges 13% as Key Melanoma Data Looms

Moderna shares soared 13% to $174.06, touching a 52-week high, as investors await pivotal Phase 3 melanoma data due October 24.

MRNA MRK
Arm Stock Soars 17% on $2B AI CPU Demand, Valuation Questioned
Technology Sarah Chen

Arm Stock Soars 17% on $2B AI CPU Demand, Valuation Questioned

Arm Holdings surged 17% to $321.83 after revealing over $2B in AGI CPU demand for fiscal 2027-2028. The rally pushed its market cap to $343B, but valuation concerns remain.

ARM META
GRAIL Soars 35% Ahead of FDA Panel, Topping All Analyst Price Targets
Markets Daniel Marsh

GRAIL Soars 35% Ahead of FDA Panel, Topping All Analyst Price Targets

GRAIL shares surge 34.7% to $108.78 two days before FDA panel review of Galleri test, outpacing all analyst price targets as investors price in approval.

GRAL
Oil Slump Boosts American Airlines as Fuel Costs Ease
Markets Daniel Marsh

Oil Slump Boosts American Airlines as Fuel Costs Ease

American Airlines gained 4% as crude oil fell 3.8%, easing fuel cost concerns. Analysts remain divided with price targets ranging from $13 to $17.

AAL DAL UAL
UK Food Price Surge Forecast as El Niño Threatens Supply Chains
Economy Daniel Marsh

UK Food Price Surge Forecast as El Niño Threatens Supply Chains

The FDF predicts UK food inflation will climb to 6.4% by July 2027, driven by El Niño and other cost pressures, testing major grocers.

TSCO
Dutch Bros Shares Plunge to 52-Week Low Despite Strong Q2 Revenue Growth
Markets Daniel Marsh

Dutch Bros Shares Plunge to 52-Week Low Despite Strong Q2 Revenue Growth

Dutch Bros (BROS) shares fell to a 52-week low of $38.28 on Monday, despite Q2 revenue surging 32.5%. Analysts remain bullish, with targets implying at least 29% upside.

BROS